At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 334 enrolled
Drug / intervention
rosuvastatindrug
Likely dose
rosuvastatin 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients
In Brief
A Phase 4 clinical trial evaluating rosuvastatin for Hypertriglyceridemia and 4 related conditions. Completed, enrolled 334 participants across 3 sites.
Detailed Summary
The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertriglyceridemia, Hyperlipoproteinemia Type IV, Hyperlipoproteinemia Type V, Hyperlipoproteinemia Type IIb, Hyperlipidemia
CountriesMexico
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2007
First PostedMay 2007
Primary CompletionFeb 2009
TodayJul 2026
First PostedMay 15, 2007
Enrollment StartJan 1, 2007
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 19.1 years ago
Interventions
rosuvastatindrug
10mg or 20mg